Skip to main content

Gene Therapy and Cancer

                                              Source- The telegraph UK

Recently, the Telegraph UK published a story that has given a number of cancer patients hope about a cure. Recently a trail conducted by USA's Kita Pharma Research for a new treatment called CAR-T cell therapy has been successful in curing 36 out of 101 patients who have terminal cancer.

How does the treatment work?

The treatment has been referred to as the living drug treatment. It works by filtering a patient's blood to remove key immune system cells called T-cells, which are then genetically engineered in the lab to recognize cancer cells. Cancer cells are very good a evading the immune system, but the new therapy essentially cuts the brakes, allowing immune cells to do their job properly.  

 (Source - http://www.telegraph.co.uk/science/2017/02/28/terminal-cancer-patients-complete-remission-one-gene-therapy/)

 A whole lot of end stage patients, who has already tried and failed to get better with traditional therapies, have seen their tumors shrink like 'ice cubes' and are in remission after just a single session. 

 The doctors however need to check the long term benefits and side effects of this new therapy. There were two people who died during the trail due to the therapy instead of cancer. 

 Its sponsor, California-based Kite Pharma, is racing Novartis AG to become the first to win approval of the treatment, called CAR-T cell therapy, in the U.S. It could become the nation’s first approved gene therapy. (Source - http://news.nationalpost.com/health/cancer-patients-in-extraordinary-gene-therapy-study-in-complete-remission-after-one-treatment?__lsa=4285-e285).There were no cases of swelling and fluid in the brain in this or any other study testing Kite’s treatment, company officials said. That contrasts with Juno Therapeutics, which has had a CAR-T study put on hold twice after five patient deaths due to this problem.


 Results were released by the company and have not been published or reviewed by other experts. Full results will be presented at the American Association for Cancer Research conference in April.The company plans to seek approval from the U.S. Food and Drug Administration by the end of March and in Europe later this year.
Labels:

Comments

Post a Comment

Popular posts from this blog

Pancreatic Rest - The cure to Diabetes type 2

Shocked? Well apparently the cure to Diabetes Mellitus or Type 2 Diabetes has been in front of our eyes all along. Type 2 diabetes, is a condition where the body fails to regulate the sugar levels in the blood causes too much or too little insulin to be produced by the pancreas. It usually turns into a life long disease requiring diet control and insulin therapy. According to new research, conducted at McMaster university in Canada, there may be hope for type 2 suffers through an intensive program that involves closely monitoring of diet+exercises+insulin+oral medicines. It basically involves giving rest to your pancreas after which your pancreases returns to normal (according to 40% of the results of study) and you are cured of diabetes or your diabetes is reversed, atleast temporarily. Here are some of the numbers as shared by McMaster University Research Program: 41% of the participants saw their diabetes reverse in just four months after the intensive program. The trial...
Post a Comment
Read more

Why the new Mental Health bill is being hailed by everyone in India right now

Mental health in India has always been greatly stigmatized. We are extremely judgmental of people who say they are depressed and approach a psychiatrist for the same. We talk behind their back and generally brand them as 'mental case'. It wasn't until recently Deepika Padukone followed by a number of other celebs disclosed being depressed and having various mental ailments that to some level it seems that we have reached a stage where we can atleast have a conversation about it.  Recently the mental health care bill of 2013 was passed, that updated a lot of definitions of what constitutes mental health. It has been hailed by the general public as a step in the right direction. Here are some of the salient features of the bill that have really been appreciated by everyone.    1. First and most importantly, the mental health bill decriminalizes suicide. Viewed as a revolutionary move, the bill acknowledges the various mental factors contributing to a person...
Post a Comment
Read more

NPPA India slashes Cancer drugs price

Nation Pharmaceutical Pricing Authority (NPPA) has been on a roll - first reducing the cost of life saving drugs and then reducing the cost of stents in India. Championing the cause of affordable medicine further, NPAA has further reduced the cost life saving cancer drugs, some by as much as 85%. The drugs include Iressa of AstraZeneca Pharma India, whose price has been bought down from Rs 29,259 to Rs 3,977, a reduction of 86 per cent and Dr Reddy's laboratories' Grafeel - the price of which has been slashed by 41 per cent, it said.  The reduction is in the price range of 86 per cent to 13 per cent, NPPA said. The other pharma players the prices of whose cancer medicines have been reduced are  Natco Pharma  and Emcure pharmaceuticals among others, it added. In the diabetes segment also, there has been reduction in prices of the drugs, the regulator said. Source (Times of India)
Post a Comment
Read more